Optimizing target inactivation to treat multidrug-resistant <i>Escherichia coli</i> with NDM and PBP3 mutations: "going the extra mile". [PDF]
Fabrizio C +13 more
europepmc +1 more source
Performance of disk diffusion, gradient test, and VITEK 2 for carbapenem susceptibility testing in OXA-48-like carbapenemase-producing <i>Enterobacterales</i>: a comparative study. [PDF]
Cimen C +5 more
europepmc +1 more source
Antimicrobial activity of piperacillin/tazobactam against key peri-implant pathogens: an in vitro comparative study with amoxicillin-clavulanate and minocycline. [PDF]
Hurtado-Celotti D +5 more
europepmc +1 more source
Comparison of broth microdilution and Etest® methods for susceptibility testing of amphotericin B in Candida auris. [PDF]
De Luca DG +8 more
europepmc +1 more source
Case Report: <i>Nocardia farcinica</i> infectious arthritis and myositis in an immunocompromised host: diagnostic and management challenges. [PDF]
Liu J, Chen Y, Sheng X, Gao Y.
europepmc +1 more source
Genetic and clinical landscape of methicillin-resistant Staphylococcus aureus isolates lacking the mec gene, in Japan. [PDF]
Natori T +7 more
europepmc +1 more source
Pharmacokinetic/pharmacodynamic parameters of teicoplanin for predicting clinical outcome of glycopeptide-susceptible <i>Enterococcus faecium</i> bacteraemia. [PDF]
Yamaguchi R +8 more
europepmc +1 more source
Comparative activity of sulbactam and sulbactam/durlobactam against carbapenem-resistant A. baumannii isolates producing OXA-23 or OXA-23 plus PER-1 enzymes. [PDF]
Mirza HC +3 more
europepmc +1 more source
Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing. [PDF]
Zaydman MA +6 more
europepmc +1 more source
<i>Enterococcus thailandicus</i> in urine. [PDF]
Stefan S +5 more
europepmc +1 more source

